The Effect of Bezafibrate on Cholestatic Itch
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Listed as NCT02701166, this PHASE3 trial focuses on Primary Biliary Cholangitis and Primary Sclerosing Cholangitis and remains ongoing. Sponsored by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), it has been updated 8 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE3
Status: Unknown Status → Unknown
-
Mar 2022 — Jul 2024 [monthly]
Unknown Status PHASE3
-
Feb 2021 — Mar 2022 [monthly]
Unknown Status PHASE3
-
Jan 2021 — Feb 2021 [monthly]
Unknown Status PHASE3
▶ Show 3 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status PHASE3
-
May 2018 — Jun 2018 [monthly]
Unknown Status PHASE3
Status: Recruiting → Unknown Status
-
Jan 2017 — May 2018 [monthly]
Recruiting PHASE3
First recorded
Feb 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- Erasmus Medical Center
- Free University Medical Center
- Friedrich-Alexander-Universität Erlangen-Nürnberg
- Istituto Clinico Humanitas
- Leiden University Medical Center
- Ludwig-Maximilians - University of Munich
- Maastricht University Medical Center
- Radboud University Medical Center
- UMC Utrecht
- University Medical Center Groningen
- University of Barcelona
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Amsterdam, Netherlands
- • Barcelona, Spain
- • Groningen, Netherlands
- • Leiden, Netherlands
- • Maastricht, Netherlands
- • Nijmegen, Netherlands
- • Rotterdam, Netherlands
- • Utrecht, Netherlands